RITROVATO, DANIELA
 Distribuzione geografica
Continente #
NA - Nord America 202
EU - Europa 176
AS - Asia 65
SA - Sud America 3
Totale 446
Nazione #
US - Stati Uniti d'America 199
IT - Italia 87
DE - Germania 27
SG - Singapore 23
HK - Hong Kong 18
IE - Irlanda 18
ID - Indonesia 14
SE - Svezia 14
RU - Federazione Russa 12
PH - Filippine 5
CA - Canada 3
CH - Svizzera 3
ES - Italia 3
AR - Argentina 2
AT - Austria 2
BE - Belgio 2
CN - Cina 2
CZ - Repubblica Ceca 2
GB - Regno Unito 2
AE - Emirati Arabi Uniti 1
BD - Bangladesh 1
BR - Brasile 1
FI - Finlandia 1
FR - Francia 1
IN - India 1
MD - Moldavia 1
UA - Ucraina 1
Totale 446
Città #
Ann Arbor 70
Chandler 25
Frankfurt am Main 23
Milan 22
Singapore 18
Hong Kong 17
Dublin 16
Jakarta 14
Ashburn 10
New York 8
Santa Clara 8
Fairfield 6
Princeton 6
Wilmington 6
Seattle 5
Cagliari 4
Naples 4
Rome 4
Tanza 4
Bisignano 3
Bologna 3
Houston 3
Lecce 3
Madrid 3
Rho 3
Trinità 3
Zurich 3
Altamura 2
Arroyo Seco 2
Bari 2
Boardman 2
Brno 2
Brussels 2
Cuggiono 2
Florence 2
Genzano di Roma 2
Lawrence 2
London 2
Mesagne 2
Montecatini Terme 2
Munich 2
Ottawa 2
Trofarello 2
Turin 2
Valsamoggia 2
Bruno 1
Cambridge 1
Chisinau 1
Gandino 1
Helsinki 1
Jinan 1
Livorno 1
Lodi 1
Manila 1
Monza 1
Narayanganj 1
Nuremberg 1
Osasco 1
Paris 1
Shanghai 1
Washington 1
Whitby 1
Woodbridge 1
Totale 348
Nome #
Sacubitril/valsartan in heart failure with reduced ejection fraction: cost and effectiveness in the Italian context 168
Valutazione economica dello scompenso cardiaco in Italia 118
Cost-effectiveness and budget impact analysis of siponimod in the treatment of secondary progressive multiple sclerosis in Italy 88
A Cross-Indication Budget Impact Model of Secukinumab for the Treatment of Psoriasis, Psoriatic Arthritis, Ankylosing Spondylitis and Non-radiographic Axial Spondyloarthritis in Italy 59
The Epidemiology, Treatment Patterns and Economic Burden of Different Phenotypes of Multiple Sclerosis in Italy: Relapsing-Remitting Multiple Sclerosis and Secondary Progressive Multiple Sclerosis 20
Retrospective Analysis of the Pharmaco-Utilization of VEGF Inhibitors and Health Care Costs among Patients with Wet Age-Related Macular Degeneration and Other Ocular Diseases in Italy 19
Totale 472
Categoria #
all - tutte 2.123
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 2.123


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202172 6 2 10 7 6 7 8 3 8 4 5 6
2021/202255 5 8 5 2 6 0 0 1 1 14 2 11
2022/2023106 7 30 11 7 17 16 0 5 7 0 1 5
2023/202494 5 4 3 9 6 21 6 10 6 15 0 9
2024/2025145 15 11 16 27 24 23 22 7 0 0 0 0
Totale 472